Publications

  1. Gupta A, Viswanatha DS, Patnaik MM. FLT3 Mutation Testing in Acute Myeloid Leukemia. JAMA Oncol 2017 Jul 01; 3 (7):991-992
    View PubMed
  2. Ding W, LaPlant BR, Call TG, Parikh SA, Leis JF, He R, Shanafelt TD, Sinha S, Le-Rademacher J, Feldman AL, Habermann TM, Witzig TE, Wiseman GA, Lin Y, Asmus E, Nowakowski GS, Conte MJ, Bowen DA, Aitken CN, Van Dyke DL, Greipp PT, Liu X, Wu X, Zhang H, Secreto CR, Tian S, Braggio E, Wellik LE, Micallef I, Viswanatha DS, Yan H, Chanan-Khan AA, Kay NE, Dong H, Ansell SM. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood 2017 Jun 29; 129 (26):3419-3427 Epub 2017 Apr 19
    View PubMed
  3. Perez Botero J, Chen D, He R, Viswanatha DS, Majerus JA, Coon LM, Nguyen PL, Reichard KK, Oliveira JL, Tefferi A, Gangat N, Pruthi RK, Patnaik MM. Clinical and laboratory characteristics in congenital ANKRD26 mutation-associated thrombocytopenia: A detailed phenotypic study of a family. Platelets 2016 Nov; 27 (7):712-715 Epub 2016 Apr 28
    View PubMed
  4. King RL, Gonsalves WI, Ansell SM, Greipp PT, Frederick LA, Viswanatha DS, He R, Kyle RA, Gertz MA, Kapoor P, Morice WG, Howard MT. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations. Am J Clin Pathol 2016 Jun; 145 (6):843-51 Epub 2016 June 21
    View PubMed
  5. He R, Greipp PT, Rangan A, Mai M, Chen D, Reichard KK, Nelsen LL, Pardanani A, Hanson CA, Viswanatha DS. BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia. Cancer Genet 2016 May; 209 (5):223-8 Epub 2016 Apr 06
    View PubMed
  6. Pulido JS, Raja H, Vile RG, Salomao DR, Viswanatha DS. Mighty MyD88 in Health and Disease. Retina 2016 Mar; 36 (3):429-31
    View PubMed
  7. Raja H, Salomao DR, Viswanatha DS, Pulido JS. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA. Retina 2016 Mar; 36 (3):624-8
    View PubMed
  8. Kortuem KM, Braggio E, Bruins L, Barrio S, Shi CS, Zhu YX, Tibes R, Viswanatha D, Votruba P, Ahmann G, Fonseca R, Jedlowski P, Schlam I, Kumar S, Bergsagel PL, Stewart AK. Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients. Blood Cancer J 2016 Feb 26; 6:e397
    View PubMed
  9. Pulido JS, Salomao DR, Frederick LA, Viswanatha DS. MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma. Retina. 2015 Apr; 35(4):624-7.
    View PubMed
  10. Bowen DA, Rabe KG, Schwager SM, Slager SL, Call TG, Viswanatha DS, Zent CS. Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A rare, but important, complication. Leuk Lymphoma. 2015; 56(2):311-4.
    View PubMed
  11. Conte MJ, Bowen DA, Wiseman GA, Rabe KG, Slager SL, Schwager SM, Call TG, Viswanatha DS, Zent CS. Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma 2014 Sep; 55 (9):2079-84 Epub 2014 Feb 17
    View PubMed
  12. Jevremovic D, Timm MM, Reichard KK, Morice WG, Hanson CA, Viswanatha DS, Howard MT, Nguyen PL. Loss of blast heterogeneity in myelodysplastic syndrome and other chronic myeloid neoplasms. Am J Clin Pathol. 2014 Sep; 142(3):292-8.
    View PubMed
  13. Frederick L, Beardell F, Viswanatha DS. Novel BCR-ABL1 fusion identified by targeted next-generation sequencing in a patient with an atypical myeloproliferative neoplasm. Hum Pathol. 2014 Aug; 45(8):1784-9. Epub 2014 May 08.
    View PubMed
  14. Zent CS, Taylor RP, Lindorfer MA, Beum PV, LaPlant B, Wu W, Call TG, Bowen DA, Conte MJ, Frederick LA, Link BK, Blackwell SE, Veeramani S, Baig NA, Viswanatha DS, Weiner GJ, Witzig TE. Chemoimmunotherapy for relapsedrefractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells. Am J Hematol 2014 Jul; 89 (7):757-65 Epub 2014 Apr 26
    View PubMed
  15. Wang X, Bledsoe KL, Graham RP, Asmann YW, Viswanatha DS, Lewis JE, Lewis JE, Chou MM, Yaszemski MJ, Jen J, Westendorf JJ, Oliveira AM. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet 2014 Jul; 46 (7):666-8 Epub 2014 May 25
    View PubMed
  16. Greipp PT, Smoley SA, Viswanatha DS, Frederick LS, Rabe KG, Sharma RG, Slager SL, Van Dyke DL, Shanafelt TD, Tschumper RC, Zent CS. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis. Br J Haematol 2013 Nov; 163 (3):326-33 Epub 2013 Aug 27
    View PubMed
  17. Endly DC, Weenig RH, Peters MS, Viswanatha DS, Comfere NI. Indolent course of cutaneous gamma-delta T-cell lymphoma. J Cutan Pathol. 2013 Oct; 40(10):896-902. Epub 2013 Feb 04.
    View PubMed
  18. West DS, Dogan A, Quint PS, Tricker-Klar ML, Porcher JC, Ketterling RP, Law ME, McPhail ED, Viswanatha DS, Kurtin PJ, Dao LN, Ritzer RD, Nowakowski GS, Feldman AL. Clonally related follicular lymphomas and Langerhans cell neoplasms: expanding the spectrum of transdifferentiation. Am J Surg Pathol. 2013 Jul; 37(7):978-86.
    View PubMed
  19. He R, Viswanatha DS. Leukemic phase of ALK-positive anaplastic large cell lymphoma. Blood. 2013 Mar 14; 121(11):1934.
    View PubMed
  20. Chen D, Bachanova V, Ketterling RP, Begna KH, Hanson CA, Viswanatha DS. A case of nonleukemic myeloid sarcoma with FIP1L1-PDGFRA rearrangement: an unusual presentation of a rare disease. Am J Surg Pathol 2013 Jan; 37 (1):147-51
    View PubMed
  21. Vasmatzis G, Johnson SH, Knudson RA, Ketterling RP, Braggio E, Fonseca R, Viswanatha DS, Law ME, Kip NS, Ozsan N, Grebe SK, Frederick LA, Eckloff BW, Thompson EA, Kadin ME, Milosevic D, Porcher JC, Asmann YW, Smith DI, Kovtun IV, Ansell SM, Dogan A, Feldman AL. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 2012 Sep 13; 120 (11):2280-9 Epub 2012 Aug 01
    View PubMed
  22. Smeltzer JP, Viswanatha DS, Habermann TM, Patnaik MM. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat. Am J Hematol. 2012 Sep; 87(9):927-8. Epub 2012 Jun 20.
    View PubMed
  23. Raza S, Viswanatha D, Frederick L, Lasho T, Finke C, Knudson R, Ketterling R, Pardanani A, Tefferi A. TP53 mutations and polymorphisms in primary myelofibrosis. Am J Hematol. 2012 Feb; 87(2):204-6. Epub 2011 Nov 4.
    View PubMed
  24. Chen D, Ketterling RP, Hanson CA, Colgan JP, Zent CS, Viswanatha DS. A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited. Am J Surg Pathol. 2011 Jul; 35(7):1080-4.
    View PubMed
  25. Jevremovic D, Viswanatha DS. Molecular diagnosis of hematopoietic and lymphoid neoplasms. Hematol Oncol Clin North Am. 2009 Aug; 23(4):903-33.
    View PubMed
  26. Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, Linda S, Martin PL, Pullen DJ, Viswanatha D, Willman CL, Winick N, Camitta BM, Children's Oncology Group. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood. 2008 Jun 15; 111(12):5477-85. Epub 2008 Apr 03.
    View PubMed
  27. Hanson CA, Steensma DP, Hodnefield JM, Nguyen PL, Hoyer JD, Viswanatha DS, Zou Y, Knudson RA, Van Dyke DL, Ketterling RP. Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance. Am J Clin Pathol. 2008 Mar; 129(3):478-85.
    View PubMed
  28. Viswanatha DS, Dogan A. Hepatitis C virus and lymphoma. J Clin Pathol. 2007 Dec; 60(12):1378-83.
    View PubMed
  29. Hayani A, Lampeter E, Viswanatha D, Morgan D, Salvi SN. First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics. 2007 Jan; 119(1):E296-E300.
    View PubMed
  30. Chen IM, Chakerian A, Devidas M, Borowitz MJ, Hunger SP, Willman CL, Viswanatha DS. Resolution of ambiguous low-level positive quantitative polymerase chain reaction results in TEL-AML1 positive ALL using a post-PCR fluorescent oligoligation method. Br J Haematol. 2006 Nov; 135(3):358-61. Epub 2006 Sep 19.
    View PubMed
  31. Starkey CR, Corn AI, Porensky RS, Viswanatha D, Wilson CS. Peripheral T-cell lymphoma with extensive dendritic cell network mimicking follicular dendritic cell tumor: a case report with pathologic, immunophenotypic, and molecular findings. Am J Clin Pathol. 2006 Aug; 126(2):230-4.
    View PubMed
  32. Merchant SH, Amin MB, Viswanatha DS. Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma: Emphasis on phenotypic aberrancies for early diagnosis. Am J Clin Pathol. 2006 Jul; 126(1):29-38.
    View PubMed
  33. Reichard KK, Zhang QY, Sanchez L, Hozier J, Viswanatha D, Foucar K. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature. Am J Hematol. 2006 Mar; 81(3):178-85.
    View PubMed
  34. Reichard KK, Burks EJ, Foucar MK, Wilson CS, Viswanatha DS, Hozier JC, Larson RS. CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol. 2005 Oct; 29(10):1274-83.
    View PubMed
  35. Merchant SH, Amin MB, Viswanatha DS, Malhotra RK, Moehlenkamp C, Joste NE. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses. Human Pathology. 2005; 36:180-186.
    View PubMed
  36. Pai RK, Chakerian AE, Binder JM, Amin M, Viswanatha DS. B-cell clonality determination using an immunoglobulin kappa light chain polymerase chain reaction method. J Mol Diagn. 2005; 7:300-307.
    View PubMed
  37. Pai RK, Snider WK, Starkey CR, Viswanatha D, Foucar MK, Wilson CS. Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings. Arch Pathol Lab Med. 2005; 129(11):1487-90.
    View PubMed
  38. Chen I-M, Chakerian A, Combs D, Garner K, Viswanatha DS. Post-PCR multiplex fluorescent ligation detection assay and flow cytometry for rapid detection of gene-specific translocations in leukemia. Am J Clin Pathol. 2004; 122:783-793.
    View PubMed
  39. Merchant SH, Haines S, Hall B, Hozier J, Viswanatha DS. Fluorescence in-situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(q22) in a case of AML-M4Eo. J Mol Diagn. 2004; 6:271-274.
    View PubMed
  40. Borowitz MJ, Pullen DJ, Shuster JJ, Viswanatha D, Montgomery K, Willman CL, Camitta B. Minimal residual disease detection in childhood precursor B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group Study Leukemia. 2003; 17:1566-1572.
  41. Fischer EG, Bocklage TJ, Rabinowitz I, Smith HO, Viswanatha DS. Primary plasmacytoma arising in an endocervical polyp with eetection of neoplastic cells on the Pap smear: report of a case and review of the literature. Arch Path Lab Med. 2003; 127:e28-e31.
    View PubMed
  42. Gaffney R, Chakerian A, O’Connell JX, Mathers J, Joste N, Viswanatha DS. Novel fluorescent ligase detection assay identifies SYT-SSX fusion type in synovial sarcoma. J Mol Diagn. 2003; 5:127-135.
    View PubMed
  43. Merchant SH, Viswanatha DS, Zumwalt RE, Foucar K. Epstein-Bar virus-associated intravascular large T-cell lymphoma presenting as acute renal failure in a patient with acquired immune deficiency syndrome. Hum Pathol. 2003; 34:950-954.
    View PubMed
  44. Viswanatha DS, Foucar K. Hodgkin and non-Hodgkin lymphoma involving bone marrow. Sem Diagn Pathol. 2003; 20(3):196-210.
  45. Zhang Q-Y, Garner K, Viswanatha DS. Rapid detection of leukemia-associated translocation fusion genes using a novel combined RT-PCR and flow cytometric method. Leukemia. 2002; 16:144-149.
    View PubMed
  46. Bartolo C, Viswanatha DS. Molecular methods for minimal residual disease detection in hematolymphoid diseases: principles and applications. J Clin Ligand Assay. 2001; 24(2):76-93.
  47. Slack JL, Willman CL, Andersen JW, Li YP, Viswanatha DS, Bloomfield CD, Tallman MS, Gallagher RE. Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129. Blood. 2000 Jan 15; 95(2):398-403.
    View PubMed
  48. Au W, Horsman DE, Viswanatha DS, Connors JM, Klasa RJ, Gascoyne RD. 8q24 translocations in blastic transformation of mantle cell lymphoma. Haematologica. 2000; 85(11):1225-1227.
    View PubMed
  49. Beaubier NT, Hart AP, Bartolo C, Willman CL, Viswanatha DS. Comparison of capillary electrophoresis and polyacrylamide gel electrophoresis for the evaluation of T and B cell clonality by polymerase chain reaction. Diagn Mol Pathol. 2000; 9(3):121-131.
    View PubMed
  50. Chao A, Gilliland F, Willman C, Joste N, Chen I, Stone N, Ruschulte J, Viswanatha D, Duncan P, Ming R, Hoffman R, Foucar E, Key C. Patient and tumor characteristics of colon cancers with microsatellite instability: a population-based study. Cancer Epidemiol Biomark Prev. 2000; 9:539-544.
  51. Evans HL, Burks E, Viswanatha D, Larson RS. Utility of immunohistochemistry in bone marrow evaluation of T-lineage large granular lymphocyte leukemia. Hum Pathol. 2000; 31(10):1266-73.
    View PubMed
  52. Viswanatha DS, Foucar K, Berry B, Gascoyne RD, Evans HL, Leith CP. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma. Mod Pathol. 2000; 13(7):823-832.
    View PubMed
  53. Au WY, Gascoyne RD, Le N, Viswanatha DS, Klasa RJ, Gallagher R, Connors JM. Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population. Ann Oncol. 1999; 10:317-321.
    View PubMed
  54. Au WY, Gascoyne RD, Viswanatha DS, Skinnider BF, Connors JM, Klasa RJ, Horsman DE. Concurrent Chromosomal Alterations at 3q27, 8q24 and 18q21 in B-cell Lymphomas. Br J Haematol. 1999; 105(2):437-440.
    View PubMed
  55. Finn LS, Viswanatha DS, Belasco JB, Snyder H, Huebner D, Sorbara L, Raffeld M, Jaffe ES, Salhany KE. Primary follicular lymphoma of the testis in childhood. Cancer. 1999; 85(7):1626-1635.
    View PubMed
  56. Gascoyne RD, Aoun P, Wu D, Chhanabhai M, Skinnider BF, Greiner TC, Morris SW, Connors JM, Vose JM, Viswanatha DS, Coldman A, Weisenburger DD. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999; 93(11):3913-3921.
    View PubMed
  57. Skinnider BF, Clement PB, MacPherson N, Gascoyne RD, Viswanatha DS. Primary non-Hodgkin's lymphoma and malakoplakia of the vagina: a case report. Hum Pathol. 1999; 30(7):871-874.
    View PubMed
  58. Rimsza LM, Viswanatha DS, Winter SS, Leith CP, Frost JD, Foucar K. The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy. Am J Clin Pathol. 1998 Sep; 110(3):313-20.
    View PubMed
  59. Viswanatha DS, Chen IM, Liu PP, Slovak ML, Rankin C, Head DR, Willman CL. Characterization and use of an antibody detecting the CBFB/SM MHC fusion protein in inv 16/t(16;16)-associated acute myeloid leukemias. Blood. 1998; 91(6):1882-1890.
    View PubMed
  60. Gallagher RE, Willman CL, Slack J, Andersen J, Li Y-P, Viswanatha DS, Bloomfield CD, Appelbaum FR, Schiffer CA, Tallman MS, Wiernik P. Association of PML-RARA fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study. Blood. 1997; 90(4):1656-1663.
    View PubMed
  61. Shum DT, Guenther L, Viswanatha D. Usefulness of the dissecting microscope in the surgical management of skin cancers. J Derm Surg Onc. 1994; 20(4):266-271.